Search Results - "Heynemann, Sarah"

Risk factors associated with suicide in adolescents and young adults (AYA) with cancer by Heynemann, Sarah, Thompson, Kate, Moncur, Donovan, Silva, Sandun, Jayawardana, Madawa, Lewin, Jeremy

“…Background Higher rates of death by suicide are recognized both in individuals of any age with cancer and, separately, among adolescents and young adults (AYA)…”
Get full text

Evaluation of Managing Cancer and Living Meaningfully (CALM) in people with advanced non-small cell lung cancer treated with immunotherapies or targeted therapies: protocol for a single-arm, mixed-methods pilot study by Lynch, Fiona Anne, Rodin, Gary, Jefford, Michael, Duffy, Mary, Lai-Kwon, Julia, Heynemann, Sarah, Mileshkin, Linda, Briggs, Lisa, Burke, John, Leigh, Lilian, Spelman, Tim, Ftanou, Maria

“…IntroductionPeople with advanced non-small cell lung cancer (NSCLC) treated with immunotherapies (IT) or targeted therapies (TT) may have improved outcomes in…”
Get full text

Developments in systemic therapies for the management of lung cancer by Heynemann, Sarah, Mitchell, Paul

“…Lung cancer accounts for approximately 1 in 10 new cancer diagnoses annually and is responsible for the most cancer‐associated deaths in Australia. Despite…”
Get full text

Relevance of sun safety in patients commencing crizotinib for non‐small cell lung cancer by Heynemann, Sarah, Mitchell, Paul

Get full text

Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era by Lai-Kwon, Julia, Heynemann, Sarah, Hart, Nicolas H, Chan, Raymond J, Smith, Thomas J, Nekhlyudov, Larissa, Jefford, Michael

Get full text

Entanglements and imagined futures: The subject(s) of precision in oncology by Flore, Jacinthe, Kokanović, Renata, Broom, Alex, Heynemann, Sarah, Lai-Kwon, Julia, Jefford, Michael

“…Precision oncology holds an increasingly powerful social function. In the era of precision, how people encounter, live with, and experience cancer, how they…”
Get full text

Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene‐addicted metastatic non‐small cell lung cancer (NSCLC) following combination chemotherapy‐immunotherapy by Heynemann, Sarah, Vanguru, Vinay, Adelstein, Stephen, Kao, Steven

“…Immune checkpoint inhibitors (ICIs) are utilized in a variety of clinical settings for the management of patients with metastatic non‐small cell lung cancer…”
Get full text

An exploration of the perceptions, experience and practice of cancer clinicians in caring for patients with cancer who are also parents of dependent-age children by Heynemann, Sarah, Philip, Jennifer, McLachlan, Sue-Anne

“…Background Being a parent alongside a cancer diagnosis presents unique challenges. It is unclear to what degree parenting considerations feature in routine…”
Get full text

Surviving metastatic non-small cell lung cancer (mNSCLC): The lived experience and supportive care needs of patients (pts) receiving immunotherapy (IT) or targeted therapy (TT) by Lai-Kwon, Julia Elizabeth, Heynemann, Sarah, Flore, Jacinthe, Duffy, Mary, Kokanovic, Renata, Jefford, Michael

“…Abstract only e24185 Background: IT and TT have improved survival for many pts with mNSCLC. However, the lived experience of these pts is under-studied. We…”
Get full text

Junior doctors voice strong desire for clinical ethics teaching by Schnall, Jesse A., Drewett, George, Heynemann, Sarah, McDougall, Rosalind, Ko, Danielle

Get full text

When research becomes practice: the concept of the therapeutic misconception and challenges to consent in clinical trials by Heynemann, Sarah, Lipworth, Wendy, McLachlan, Sue‐Anne, Philip, Jennifer, John, Tom, Kerridge, Ian

“…Many factors influence patients' decisions to participate in clinical trials. For many, the primary motivation is the possibility that they might derive some…”
Get full text

Supporting cancer care clinicians to ‘hold’ their patients during and beyond the COVID‐19 pandemic: a role for reflective ethics discussions by Delany, Clare, Benhamu, Joanne, McDougall, Rosalind, Ko, Danielle, Jones, Hayley, Mileshkin, Linda, Largey, Geraldine, Clinch, Alex, Heynemann, Sarah

“…The COVID‐19 pandemic has placed an overwhelming burden on healthcare delivery globally. This paper examines how COVID‐19 has affected cancer care clinicians'…”
Get full text

Therapeutic misunderstandings in modern research by Heynemann, Sarah, Lipworth, Wendy, McLachlan, Sue‐Anne, Philip, Jennifer, John, Tom, Kerridge, Ian

“…Clinical trials play a crucial role in generating evidence about healthcare interventions and improving outcomes for current and future patients. For…”
Get full text

Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy by Lai-Kwon, Julia, Heynemann, Sarah, Flore, Jacinthe, Dhillon, Haryana, Duffy, Mary, Burke, John, Briggs, Lisa, Leigh, Lillian, Mileshkin, Linda, Solomon, Benjamin, Ball, David, Kokanovic, Renata, Jefford, Michael

“…Purpose Immunotherapy (IT) and targeted therapy (TT) have improved survival for some patients with metastatic non-small cell lung cancer (NSCLC). Their lived…”
Get full text

Alectinib induces marked red cell spheroacanthocytosis in a near-ubiquitous fashion and is associated with reduced eosin-5-maleimide binding by Kuzich, James A., Heynemann, Sarah, Geoghegan, Niall, Evelyn, Cindy, O'Mahoney, Susan, Wilson, Susan, Campbell, Janine, Rogers, Kelly, Solomon, Benjamin, Westerman, David, Pasricha, Sant-Rayn

“…We reviewed haematological investigations for 43 patients treated at a single centre with alectinib, an inhibitor of anaplastic lymphoma kinase (ALK) which is…”
Get full text

Squamous cell carcinoma differentiation at progression as a resistance mechanism in metastatic non-small cell lung carcinoma harbouring a targetable mutation by Heynemann, Sarah, Prosser, N, Lee, J, Mahar, A, Anderson, L, Kao, S, Cooper, W A

Get full text

To be mortal is human: professional consensus around the need for more psychology in palliative care by Sansom-Daly, Ursula M, Lobb, Elizabeth A, Evans, Holly E, Breen, Lauren J, Ugalde, Anna, Best, Megan, Zomerdijk, Nienke, Beasley, Elizabeth A, Taylor, Keryn L, Clayton, Josephine, Sharpe, Louise, Bartula, Iris, Olver, Ian

Get more information

Relevance of sun safety in patients commencing crizotinib for non-small cell lung cancer by Heynemann, Sarah, Mitchell, Paul

Get full text

Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy by Heynemann, Sarah, Vanguru, Vinay, Adelstein, Stephen, Kao, Steven

“…Immune checkpoint inhibitors (ICIs) are utilized in a variety of clinical settings for the management of patients with metastatic non-small cell lung cancer…”
Get full text